|Previous Section||Index||Home Page|
Mr. Burrowes: To ask the Secretary of State for Health how many people aged (a) under 18 and (b) between 18 and 21 years old were prescribed (i) methadone, (ii) subutex and (iii) other synthetic opiates by health professionals in the latest period for which figures are available. 
The latest national statistics on young people in drug treatment show that in 2008-09 there were the following numbers of under-18s receiving pharmacological interventions and combinations of this with other interventions.
National Treatment Agency for Substance Misuse (NTA)
Pharmacological interventions are interventions which include prescribing for detoxification, stabilisation and symptomatic relief of substance misuse as well as prescribing of medications to prevent relapse. These would include methadone, buprenorphine and other synthetic opiates.
Mr. Mike O'Brien: Information is not held in the format requested. However, the following data show the number of general practitioners (GP)-registered patients in South East Essex Primary Care Trust (PCT) from 2002 to 2008.
|South East Essex PCT|
|Number of GP-registered patients|
1. South East Essex PCT was created on 1 October 2006 from a complete merger of Castle Point and Rochford PCT and Southend-on-Sea PCT.
2. Figures prior to 2006 are an aggregate of these predecessor organisations. It is impossible to map workforce figures for these organisations prior to the creation of the PCTs in 2002.
3. Figures provided show numbers of patients registered with a GP as at 30 September each year. Data on patient transactions or newly registered patients are not available on the annual GP census.
The NHS Information Centre for health and social care General and Personal Medical Services Statistics.
Mr. Andrew Turner: To ask the Secretary of State for Health what estimate he has made of the cost to the NHS of (a) emergency and (b) non-emergency treatment of people from (i) each EU member state, (ii) Jersey and (iii) the Isle of Man in each of the last five years. 
Claims made by the UK for recovering the cost of treatment provided to people from other European Economic Area (EEA) countries are shown in the following table. The claims cannot be broken down by treatment type.
|EEA medical costs: claims by UK against member states-actual claims submitted for claim years 2005 to 2009|
1. Under European Union regulations claims relate to calendar years.
2. Due to the nature of the EU claims process member states (including the UK) may submit claims in arrears, often several years in arrears, and the settlement process for any one claim may extend over several years. Smaller supplementary claims may also be made, sometimes several years after main claims. Claims totals given are therefore a snapshot based on the current position, and are subject to change.
3. Totals for UK claims will include formula-based claims for temporary visitor costs under bilateral arrangements which provide for reimbursement linked to tourist numbers.
4. UK claims under those bilateral arrangements for years 2007 and later have yet to be submitted. These will be submitted following the publication by the European Commission of the UK's average costs for those years, as data from those average costs are used in the calculation of claims. However, in some cases advance claim payments may be made under bilateral arrangements prior to the submission of the claim. Such advance claim payments will be reflected in the totals included in the table.
Mr. Leech: To ask the Secretary of State for Health (1) what guidance his Department has provided on the implementation of the proposal in his Department's strategy for children and young people's health that all children with complex health needs should have an individual care plan by 2010; and if he will make a statement; 
(2) what progress his Department has made on the implementation of the proposals in his Department's strategy for children and young people's health that all children with complex health needs should have an individual care plan by 2010; what estimate he has made of the number of children with complex health needs who have been given such a plan; and if he will make a statement. 
Ann Keen: Guidance for commissioners on how to commission personalised care planning for adults and children with long-term conditions was issued in January 2009. The care planning commitment for children with complex needs was affirmed in 'Healthy Lives, Brighter Futures' which emphasises the need to ensure high quality, timely and accessible support and sets out a clear expectation that children's trust partners will provide children and families with accessible and comprehensive information about the services, advice and support available.
Progress is being sustained through the Long Term Conditions programme which includes work to support and accelerate implementation of care planning; elements of which are a Primary Care Service Specification to support commissioners and to incentivise delivery in primary care, and a leaflet for families explaining the benefits of care planning. Assessing the demand and providing for individual care plans for children with complex conditions is for local decision based on local assessment of need.
However, the Department supports the national programme for substance abuse deaths (npSAD), currently run by the International Centre for Drug Policy at St. Georges, University of London. This programme collects and analyses data on drug related deaths in the United Kingdom, and can be found at the following website at:
|Next Section||Index||Home Page|